KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) EBT Margin Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,280.00
Dec 31, 2025 2,693.00
Sep 30, 2025 -1,485.00
Jun 30, 2025 1,672.00
Mar 31, 2025 -2,350.00
Dec 31, 2024 -5,034.00
Sep 30, 2024 -919.00
Jun 30, 2024 506.00
Mar 31, 2024 -1,824.00
Dec 31, 2023 3,705.00
Sep 30, 2023 -1,950.00
Jun 30, 2023 -548.00
Mar 31, 2023 -3,137.00
Dec 31, 2022 419.00
Sep 30, 2022 -24.00
Jun 30, 2022 -2,577.00
Mar 31, 2022 450.00
Dec 31, 2021 -71.00
Sep 30, 2021 -560.00
Jun 30, 2021 -2,415.00
Mar 31, 2021 -9.00
Dec 31, 2020 -4,094.00
Sep 30, 2020 -833.00
Jun 30, 2020 -157,487.00
Mar 31, 2020 825.00
Dec 31, 2019 5,434.00
Sep 30, 2019 991.00
Jun 30, 2019 -1,931.00
Mar 31, 2019 432.00
Dec 31, 2018 -5,673.00
Sep 30, 2018 592.00
Jun 30, 2018 -485.00
Mar 31, 2018 663.00
Dec 31, 2017 -1,749.00
Sep 30, 2017 -563.00
Jun 30, 2017 268.00
Mar 31, 2017 780.00